An ability to speak the pricing, reimbursement, market access, pricing, forecasting language of the commercial teams (e.g., price, reimbursement, launch sequence by indication/geography) and that of their medical and R&D colleagues (e.g., evidence generation, significance of clinical results, length of trials, endpoints). Add to that a breadth of experience in the field of US, but also Global reimbursement and pricing, where complex policies and rules shape commercial and R&D strategic decisions. The challenges and pressures are growing out there. No market is insulated; our clients have to think globally while acting locally, working hand in hand to ensure common growth and success. I can help them do that.